SPDR S&P Biotech ETF
292 hedge funds and large institutions have $3.09B invested in SPDR S&P Biotech ETF in 2017 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 100 increasing their positions, 78 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
292
Holders Change
+18
Holders Change %
+6.57%
% of All Funds
7.28%
Holding in Top 10
12
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+100%
% of All Funds
0.3%
New
67
Increased
100
Reduced
78
Closed
48
Calls
$656M
Puts
$1.19B
Net Calls
-$530M
Net Calls Change
-$222M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$234M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$254M |
| 3 |
3
BNP Paribas Financial Markets
Paris,
France
|
$265M |
| 4 |
4
AssetMark Inc
Concord,
California
|
$95.4M |
| 5 |
5
Citigroup
New York
|
$335M |
